Who Are the Leading GLP-1 Drug Manufacturers
Similar economic benefits have been observed in other therapeutic areas where peptides provide superior clinical outcomes
Notably, older adults with obesity and preserved baseline muscle mass represent a particularly understudied phenotype, and dedicated studies are needed to determine whether this subgroup may differentially benefit from the muscle quality improvements associated with GLP-1 RA therapy
The most reliable data comes from a 2020 systematic review and meta-analysis of 37 randomized controlled trials (about 2,300 participants)
Reduced caloric intake is one hypothesis
doi: 10.1007/s11434-014-0722-7 Summary Keywords non-alcoholic liver disease, vitamin B12 concentrations, liver enzymes, Mendelian randomization, genome-wide association studies Citation Fu L, Wang Y and Hu Y-Q (2023) Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data
